Abstract
Forty patients of both sexes, aged between 25 and 65 years and suffering from gonarthrosis, took part in a controlled double-blind study of Proxen vs naproxen. Proxen was administered to 20 patients and the control drug to the other 20, in doses of 500 mg twice a day for 60 days. Both drugs demonstrated a good level of activity and tolerance. Proxen proved effective in 94% of the cases, while naproxen was effective in 80%.
Publication types
-
Clinical Trial
-
Comparative Study
-
Controlled Clinical Trial
MeSH terms
-
Adult
-
Aged
-
Anti-Inflammatory Agents, Non-Steroidal / adverse effects
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
-
Arthritis / drug therapy*
-
Double-Blind Method
-
Female
-
Humans
-
Knee Joint*
-
Male
-
Middle Aged
-
Naproxen / adverse effects
-
Naproxen / therapeutic use
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Naproxen